首页> 美国卫生研究院文献>Vaccines >A National Survey to Assess the COVID-19 Vaccine-Related Conspiracy Beliefs Acceptability Preference and Willingness to Pay among the General Population of Pakistan
【2h】

A National Survey to Assess the COVID-19 Vaccine-Related Conspiracy Beliefs Acceptability Preference and Willingness to Pay among the General Population of Pakistan

机译:国家调查评估了Covid-19与疫苗相关的阴谋信念可接受性偏好以及在巴基斯坦一般人口中支付的愿意

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The current study aims to assess the beliefs of the general public in Pakistan towards conspiracy theories, acceptance, willingness to pay, and preference for the COVID-19 vaccine. A cross-sectional study was conducted through an online self-administered questionnaire during January 2021. The Chi-square test or Fisher exact test was utilized for statistical data analysis. A total of 2158 respondents completed the questionnaire, among them 1192 (55.2%) were male with 23.87 (SD: ±6.23) years as mean age. The conspiracy beliefs circulating regarding the COVID-19 vaccine were believed by 9.3% to 28.4% of the study participants. Among them, 1040 (48.2%) agreed to vaccinate on its availability while 934 (43.3%) reported the Chinese vaccine as their preference. The conspiracy beliefs of the participants were significantly associated with acceptance of the COVID-19 vaccine. The existence of conspiracy beliefs and low vaccine acceptance among the general population is a serious threat to successful COVID-19 vaccination.
机译:目前的研究旨在评估巴基斯坦公众对阴谋理论,接受,支付愿意的愿望,以及对Covid-19疫苗的偏好。通过在2021年1月的在线自我管理的问卷进行横截面研究。Chi-Square测试或Fisher精确测试用于统计数据分析。共有2158名受访者完成了调查问卷,其中1192(55.2%)是男性,23.87(SD:±6.23)年龄为平均年龄。关于Covid-19疫苗的引人的信念被认为是研究参与者的9.3%至28.4%。其中,1040(48.2%)同意接种其可用性,而934(43.3%)报告中国疫苗作为他们的偏好。参与者的阴谋信仰与接受Covid-19疫苗有显着相关。在一般人群中存在阴谋信念和低疫苗接受是对Covid-19疫苗接种成功的严重威胁。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号